Related Experiment Video
Updated: May 26, 2025

07:37
A Rat Lung Transplantation Model of Warm Ischemia/Reperfusion Injury: Optimizations to Improve Outcomes
Published on: October 28, 2021
2.9K
Development of a Machine Learning-Powered Optimized Lung Allocation System for Maximum Benefits in Lung
Mihyang Ha1,2,3, Woo Hyun Cho4,5, Min Wook So6
1Interdisciplinary Program of Genomic Data Science, Pusan National University, Busan, Korea.
Journal of Korean Medical Science
|February 25, 2025
Summary
A new MaxBenefit Lung Allocation Score (LAS) system was developed to improve lung transplant outcomes. This novel LAS balances candidate urgency with post-transplant survival, aiming to reduce waitlist deaths and enhance equitable organ distribution.
Area of Science:
- Transplantation research
- Medical informatics
- Biostatistics
Background:
- Current lung allocation systems aim to minimize waitlist deaths, improve transplant survival, and ensure fairness.
- Developing an optimal lung allocation score (LAS) is crucial for maximizing transplant benefits.
Purpose of the Study:
- To develop and validate a novel lung allocation score (LAS) system, termed MaxBenefit LAS.
- To maximize overall transplant benefits by balancing waitlist urgency and post-transplant survival.
Main Methods:
- Retrospective analysis of 1,599 lung transplant candidates from the Korean Network for Organ Sharing database (2009-2020).
- Development of the MaxBenefit LAS using elastic-net Cox regression, combining waitlist mortality and post-transplant survival models.
- Performance assessment using Area Under the Curve (AUC) and Uno's C-index, compared against the US LAS.
Main Results:
- The waitlist mortality model demonstrated strong predictive performance (AUC: 0.834 training, 0.818 validation).
- The post-transplant survival model showed good predictive ability (AUC: 0.708 training, 0.685 validation).
- MaxBenefit LAS effectively stratified risk, outperforming conventional LAS in predicting waitlist death and identifying candidates with greater transplant benefits.
Conclusions:
- The MaxBenefit LAS presents a promising strategy for optimizing lung allocation.
- This system balances candidate urgency with post-transplant survival likelihood.
- It has the potential to improve lung transplant recipient outcomes and reduce waitlist mortality through equitable organ allocation.

